Role of the HLA class II: HCV-related disorders

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 308-318

  De Re, Valli ^a,m   Caggiari, Laura ^a   Simula, Maria Paola ^a   De Vita, Salvatore ^b   Mazzaro, Cesare ^c   Lenzi, Marco ^d   Galli M , Massimo ^e   Monti, Giuseppe ^f   Ferri, Clodoveo ^g   Zignego, Anna Linda ^h   Gabrielli, Armando ⁱ   Sansonno, Domenico ^j   Dammacco, Franco ^j   Libra, Massimo ^k   Sacchi, Nicoletta ^l   Talamini, Renato ^a   Spina, Michele ^a   Tirelli, Umberto ^a   Cannizzaro, Renato ^a   Dolcetti, Riccardo ^a  

^a Aviano National Cancer Institute   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c Pordenone Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f Ospedale di Saronno   (Italy)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k UNIVERSITY OF CATANIA   (Italy)

^l Registro Italiano Donatori di Midollo Osseo (AiBT) Eo Ospedali Gallieri of Genova   (Italy)

^m CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

more..

Author keywords

B cell lymphoproliferation; Cryoglobulinemia; Hepatitis C virus; Hepatocarcinoma; HLA DQB1; HLA DRB1; Lymphoma; MHC allele; SBT; Sequence based typing

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

CHEMICAL STRUCTURE; CONFERENCE PAPER; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; HELPER CELL; HEPATITIS C; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHODGKIN LYMPHOMA; RISK FACTOR; T LYMPHOCYTE ACTIVATION; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; FIBROSIS; HEPATITIS C VIRUS; IMMUNOLOGY; LIVER TUMOR; PATHOGENICITY; PATHOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; FIBROSIS; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LIVER NEOPLASMS; LYMPHOMA, B-CELL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 34648817580     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.033     Document Type: Conference Paper

References (42)

1. NEPOM, G.T. & H. ERLICH. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9: 493-525.
2. ROBINSON, J. et al. 2003. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31: 311-314.
3. ACCAPEZZATO, D. et al. 2004. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113: 963-972.
4. TSAI, S.L. et al. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25: 449-458.
5. ZIGNEGO, A.L. 2004. Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues. J. Hepatol. 41: 1045-1049.
6. CABRERA, R. Z. et al. 2004. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
7. BOETTLER, T. et al. 2005. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J. Virol. 79: 7860-7867.
8. RUSHBROOK, S.M. et al. 2005. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79: 7852-7859.
9. BOYER, O. et al. 2004. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103: 3428-3430.
10. WOITAS, R.P. et al. 1997. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J. Immunol. 159: 1012-1018.
11. RACANELLI, V. & B. REHERMANN. 2006. The liver as an immunological organ. Hepatology 43: S54-S62.
12. SHEVACH, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
13. ORMANDY, L.A. et al. 2005. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65: 2457-2464.
14. DIEPOLDER, H.M. et al. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
15. MISSALE, G. et al. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98: 706-714.
16. DOYTCHINOVA, I.A. & D.R. FLOWER. 2005. In silico identification of supertypes for class II MHCs. J. Immunol. 174: 7085-7095.
17. SUGIMOTO, K. et al. 2003. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology 37: 590-599.
18. BARRETT, S. et al. 2001. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 49: 423-430.
19. FANNING, L.J. et al. 2001. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 33: 224-230.
20. GODKIN, A. et al. 2001. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur. J. Immunol. 31: 1438-1446.
21. KUSUMOTO, K. et al. 2006. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34: 24-31.
22. PALADINO, N. et al. 2006. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J. Virol. 80: 9144-9150.
23. DE MARIA, A. et al. 2007. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37: 445-455.
24. WAGONER, J. et al. 2007. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J. Virol. 81: 309-318.
25. DOLGANIUC, A. et al. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170: 5615-5624.
26. SAROBE, P. et al. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J. Virol. 77: 10862-10871.
27. KALAMS, S.A. & B.D. WALKER. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188: 2199-2204.
28. LOPEZ-VAZQUEZ, A. et al. 2004. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis. 189: 957-963.
29. PELLEGRIS, G. et al. 2002. B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma. J. Hepatol. 36: 521-526.
30. RICCI, G. et al. 1995. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects. Cancer Lett. 98: 121-125.
31. DE RE, V. et al. 2004. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Hum. Immunol. 65: 1397-1404.
32. ALRIC, L. et al. 1997. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 113: 1675-1681.
33. SANSONNO, D. et al. 2004. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur. J. Immunol. 34: 126-136.
34. SANSONNO, D. et al. 2007. Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin. Exp. Immunol. 147: 241-248.
35. DE RE, V. et al. 2006. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology 45: 685-693.
36. HUNZIKER, L. et al. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4: 343-349.
37. ROSA, D. et al. 2005. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA 102: 18544-18549.
38. LANZAVECCHIA, A. & F. SALLUSTO. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
39. DE RE, V. et al. 2000. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96: 3578-3584.
40. DE RE, V. et al. 2006. An Italian multicenter controlled study of HCV-related malignancies: Role of the HLA class II. Dig. Liver Dis. 38: S30.
41. DE RE, V. et al. Submitted. HLA class II polymorphism identifies two clinically distinct subtypes of B-cell non-Hodgkin's lymphomas rising in patients with chronic hepatitis C virus infection.
42. NIETERS, A. et al. 2006. Hepatitis C and risk of lymphoma: results of the European Multicenter Case-Control Study Epilymph. Gastroenterology 131: 1879-1886.